MedTrace Logo

Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)

NCT02374853 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1037

Last updated 2022-11-03

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to determine if using the antibiotic vancomycin as a preventative topical (on the surface of the skin) treatment during open-heart surgery will reduce the risk of developing a sternal wound infection.

Conditions

Interventions

DRUG

Vancomycin

Topical prophylactic antibiotic

OTHER

No Vancomycin

Placebo: Sterile water. No Vancomycin.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Abbas Khani-Hanjani, MD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2019-04-30
Completion
2019-04-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02374853 on ClinicalTrials.gov